REGENXBIO
Rockville, United States (US) · Science and Engineering
Do your work at REGENXBIO?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
Jun 2026
REGENXBIO is a Science and Engineering company based in Rockville, United States (US), founded in 2008, with 200-500 employees. REGENXBIO's profile is verified on Enterprise League.
Overview
REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines. REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, RGX-202 for the treatment of Duchenne and RGX-121 for the treatment of MPS II. Thousands of patients have been treated with REGENXBIO’s AAV Therapeutic platform, including Novartis’ ZOLGENSMA for children with spinal muscular atrophy. Designed to be one-time treatments, AAV Therapeutics have the potential to change the way healthcare is delivered for millions of people.
Contact Details
info@regenxbio.com
Rockville, United States (US)
Founded
2008
Employees
200-500
Categories
Keywords
#Biotechnology
#Biopharmaceuticals
#Gene Therapy
Companies teams usually look at after REGENXBIO
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.